Prospective Immune Dynamics during the First 24 Weeks of Efavirenz Based-Antiretroviral Therapy in HIV-1-Infected Subjects, According to CD4(+) T-Cell Counts at Presentation: The IMMUNEF Clinical Trial

BACKGROUND: Longitudinal characterization of immune recovery in the first-phase of antiretroviral therapy (ART) is poorly described. We compared immune kinetics in individuals who were diagnosed early or late with HIV-1 infection, (thus commencing ART with different CD4(+) T-cell counts), in order t...

Descripción completa

Detalles Bibliográficos
Autores principales: Soria, Alessandro, Trabattoni, Daria, Squillace, Nicola, Rainone, Veronica, Gnudi, Federica, Clerici, Mario, Gori, Andrea, Bandera, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324909/
https://www.ncbi.nlm.nih.gov/pubmed/25671649
http://dx.doi.org/10.1371/journal.pone.0117118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324909/
https://www.ncbi.nlm.nih.gov/pubmed/25671649
http://dx.doi.org/10.1371/journal.pone.0117118

Ejemplares similares